RNA-Seq profiling of circular RNAs in human laryngeal squamous cell carcinomas
Open Access
- 1 May 2018
- journal article
- research article
- Published by Springer Nature in Molecular Cancer
- Vol. 17 (1) , 86
Abstract
Abnormal expression of non-coding circular RNAs (circRNAs) have been reported in many types of tumors. circRNA have been suggested to be an ideal candidate biomarker for diagnostic and therapeutic implications in cancers. The aim of this study was to assess the circRNA expression profile of laryngeal squamous cell carcinomas (LSCC). The biopsy samples from patients with LSCC were obtained intra-operatively. The circRNA expression was performed using secondary sequencing. Among 10 patients with LSCC, 2 were well differentiated, 3 were moderately differentiated and 5 were adjunctive samples with normal and LSCC tissues. A total of 21,444 distinct circRNA candidates were detected. Among them, we defined the statistical criteria for selecting aberrant-expressed circRNA using a q-value of < 0.001 with a fold change of > 2.0 or < 0.5. A total of 29 circRNA were upregulated and 19 circRNA were downregulated significantly in the LSCC tissues. The intersection of these dysregulated circRNAs of normal-well differentiated set and normal-moderately differentiated set was then assessed to narrow the upregulated and downregulated circRNAs down to 18 and 5 respectively. Furthermore, an association of the circRNA-miRNA-mRNA was investigated, showing that 20 dysregulated circRNA successfully predicted an interaction with several cancer-related miRNAs. Finally, a further KEGG analysis showed that PPAR, Axon guidance, Wnt and Cell cycle signaling pathway were key putative pathways in the process of LSCC. hsa_circ:chr20:31876585–31,897,648 was found to be able to differentiate most of LSCC from the matching normal tissues. This observational study demonstrated dysregulation of circRNA in LSCC, which may have an impact on development of potential biomarkers in this disease. Validation of down-regulation of hsa_circ:chr20:31876585–31,897,648 in LSCC compared to each adjunctive tissue by Q-RT-PCR, indicating that hsa_circ:chr20:31876585–31,897,648 may be a novel promising tumor suppresser in LSCC.Keywords
Funding Information
- Beijing Municipal Commission of Education (KM201510025028)
- Research Foundation of Beijing Friendship Hospital (yydszx2015-02, yyqdkt2014-23)
- National Natural Science Foundation of China (81470684)
- Clinical Special Fund of Jiangsu Province (b12014032)
This publication has 10 references indexed in Scilit:
- Microarray profiling of circular RNAs in human papillary thyroid carcinomaPLOS ONE, 2017
- Circular RNA expression in cutaneous squamous cell carcinomaJournal of Dermatological Science, 2016
- Circular RNA: a novel biomarker for progressive laryngeal cancer.2016
- Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathwayOncotarget, 2015
- Complementary Sequence-Mediated Exon CircularizationCell, 2014
- Detecting and characterizing circular RNAsNature Biotechnology, 2014
- Ten-year retrospective study of head and neck carcinoma in situ: incidence, treatment, and clinical outcomeOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2013
- microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signalingRadiotherapy and Oncology, 2011
- Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cellsOncogene, 2011
- Patterns of Care for Cancer of the Larynx in the United StatesJAMA Otolaryngology–Head & Neck Surgery, 1997